Cite
HARVARD Citation
Saiz‐Rodríguez, M. et al. (2019). CYP2C19 Ultrarapid Phenotype as a Risk Predictor of Subsequent Events During Clopidogrel Treatment in Patients Undergoing a Percutaneous Neurointervention. Clinical pharmacology & therapeutics. 105 (5), pp. 1074-1075. [Online].